Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miaoxia He

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Cancer Research and Clinical Oncology|February 16, 2010
Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinomaMingzhen Ying, Dawei Li, Linjun Yang, et al.
Pancreas|December 19, 2014
A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4Ke Yang, Miaoxia He, Zailong Cai, et al.
Zhonghua Nei Ke Za Zhi|December 18, 2015
[IgG4-related lung disease:a clinical analysis and literature review]Xinghua Shan, Xiaomeng Nie, Xiao Yong, et al.
Journal of Cancer|June 7, 2021
Aggregative Perivascular Tumor Cell Growth Pattern of Primary Central Nervous System Lymphomas Is Associated with Hypoxia-Related Endoplasmic Reticulum StressMiaoxia He, Weiwei Zhang, Jianjun Wang, et al.
Theranostics|October 14, 2020
Targeting BCL10 by small peptides for the treatment of B cell lymphomaWei Bao, Chenxia Sun, Xiaochen Sun, et al.
Cell Death & Disease|January 21, 2018
HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphomaXinying Zhao, Xudong Guo, Libo Xing, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphomaWenqin Yue, Bin Liu, Lei Gao, et al.
Clinical and Experimental Medicine|June 27, 2025
Integrated analysis of CD30 detection methodologies and synergistic drug combinations for optimizing brentuximab vedotin therapy in lymphomaMingyu Ye, Tao Wang, Zhiqiang Song, et al.
Acta Neuropathologica Communications|January 24, 2026
Deficiency of SMARCB1 drives an immunosuppressive microenvironment in meningiomaBen Jin, Hao Hu, Yanhua Lu, et al.
Frontiers in Oncology|October 18, 2021
Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT CarcinomaXiang Li, Hui Shi, Wei Zhang, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Cancer Research and Clinical Oncology|February 16, 2010
Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinomaMingzhen Ying, Dawei Li, Linjun Yang, et al.
Pancreas|December 19, 2014
A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4Ke Yang, Miaoxia He, Zailong Cai, et al.
Zhonghua Nei Ke Za Zhi|December 18, 2015
[IgG4-related lung disease:a clinical analysis and literature review]Xinghua Shan, Xiaomeng Nie, Xiao Yong, et al.
Journal of Cancer|June 7, 2021
Aggregative Perivascular Tumor Cell Growth Pattern of Primary Central Nervous System Lymphomas Is Associated with Hypoxia-Related Endoplasmic Reticulum StressMiaoxia He, Weiwei Zhang, Jianjun Wang, et al.
Theranostics|October 14, 2020
Targeting BCL10 by small peptides for the treatment of B cell lymphomaWei Bao, Chenxia Sun, Xiaochen Sun, et al.
Cell Death & Disease|January 21, 2018
HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphomaXinying Zhao, Xudong Guo, Libo Xing, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphomaWenqin Yue, Bin Liu, Lei Gao, et al.
Clinical and Experimental Medicine|June 27, 2025
Integrated analysis of CD30 detection methodologies and synergistic drug combinations for optimizing brentuximab vedotin therapy in lymphomaMingyu Ye, Tao Wang, Zhiqiang Song, et al.
Acta Neuropathologica Communications|January 24, 2026
Deficiency of SMARCB1 drives an immunosuppressive microenvironment in meningiomaBen Jin, Hao Hu, Yanhua Lu, et al.
Frontiers in Oncology|October 18, 2021
Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT CarcinomaXiang Li, Hui Shi, Wei Zhang, et al.
Pageof 4